A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants

Hong Shen(Shihezi University), Michael Sinz(Rutgers, The State University of New Jersey), Kofi Boamah Mensah(Kwame Nkrumah University of Science and Technology), Andrew J. Paris(University of Pennsylvania), Linna Wang(Bristol-Myers Squibb (Germany)), Runlan Huo(Bristol-Myers Squibb (Germany)), Weiqi Chen, Min Chen(Nanjing Agricultural University), Wenying Li(Bristol-Myers Squibb (Germany)), Nian Tong(Bristol-Myers Squibb (Germany)), Yongjun Xue(Bristol-Myers Squibb (Germany)), Yueping Zhang(Institute of Vegetables and Flowers)
Journal of Pharmacology and Experimental Therapeutics
January 31, 2024
Cited by 15


Related Papers